These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33033376)

  • 1. Author Correction: PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
    Hou J; Zhao R; Xia W; Chang CW; You Y; Hsu JM; Nie L; Chen Y; Wang YC; Liu C; Wang WJ; Wu Y; Ke B; Hsu JL; Huang K; Ye Z; Yang Y; Xia X; Li Y; Li CW; Shao B; Tainer JA; Hung MC
    Nat Cell Biol; 2020 Nov; 22(11):1396. PubMed ID: 33033376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
    Hou J; Zhao R; Xia W; Chang CW; You Y; Hsu JM; Nie L; Chen Y; Wang YC; Liu C; Wang WJ; Wu Y; Ke B; Hsu JL; Huang K; Ye Z; Yang Y; Xia X; Li Y; Li CW; Shao B; Tainer JA; Hung MC
    Nat Cell Biol; 2020 Oct; 22(10):1264-1275. PubMed ID: 32929201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author Correction: Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination.
    Gilad Y; Eliaz Y; Yu Y; Han SJ; O'Malley BW; Lonard DM
    Sci Rep; 2020 Mar; 10(1):4463. PubMed ID: 32132607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer.
    Ahn S; Lee JC; Shin DW; Kim J; Hwang JH
    Sci Rep; 2020 Dec; 10(1):21552. PubMed ID: 33273671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.
    Song P; Zhang J; Shang C; Zhang L
    Sci Rep; 2020 Jan; 10(1):1525. PubMed ID: 31988322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1.
    Yu J; Qin B; Moyer AM; Nowsheen S; Tu X; Dong H; Boughey JC; Goetz MP; Weinshilboum R; Lou Z; Wang L
    Cell Res; 2020 Sep; 30(9):823. PubMed ID: 32636455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
    Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
    Nature; 2019 Jul; 571(7766):E10. PubMed ID: 31270456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
    Liu C; Yao Z; Wang J; Zhang W; Yang Y; Zhang Y; Qu X; Zhu Y; Zou J; Peng S; Zhao Y; Zhao S; He B; Mi Q; Liu X; Zhang X; Du Q
    Cell Death Differ; 2020 Jul; 27(7):2293. PubMed ID: 32024980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Author Correction: Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.
    Epeldegui M; Conti DV; Guo Y; Cozen W; Penichet ML; Martínez-Maza O
    Sci Rep; 2020 Jan; 10(1):748. PubMed ID: 31937870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Author Correction: Early endosome autoantigen 1 regulates IL-1β release upon caspase-1 activation independently of gasdermin D membrane permeabilization.
    Baroja-Mazo A; Compan V; Martín-Sánchez F; Tapia-Abellán A; Couillin I; Pelegrín P
    Sci Rep; 2020 Dec; 10(1):21356. PubMed ID: 33262522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Author Correction: Tumour lineage shapes BRCA-mediated phenotypes.
    Jonsson P; Bandlamudi C; Cheng ML; Srinivasan P; Chavan SS; Friedman ND; Rosen EY; Richards AL; Bouvier N; Selcuklu SD; Bielski CM; Abida W; Mandelker D; Birsoy O; Zhang L; Zehir A; Donoghue MTA; Baselga J; Offit K; Scher HI; O'Reilly EM; Stadler ZK; Schultz N; Socci ND; Viale A; Ladanyi M; Robson ME; Hyman DM; Berger MF; Solit DB; Taylor BS
    Nature; 2020 Jan; 577(7789):E1. PubMed ID: 31822847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gasdermins: Pore-forming Proteins as a Potential Therapeutic Target.
    Jain K; Barve K; Bhatt LK
    Curr Protein Pept Sci; 2022; 23(3):133-151. PubMed ID: 35538820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.
    Rupaimoole R; Wu SY; Pradeep S; Ivan C; Pecot CV; Gharpure KM; Nagaraja AS; Armaiz-Pena GN; McGuire M; Zand B; Dalton HJ; Filant J; Miller JB; Lu C; Sadaoui NC; Mangala LS; Taylor M; van den Beucken T; Koch E; Rodriguez-Aguayo C; Huang L; Bar-Eli M; Wouters BG; Radovich M; Ivan M; Calin GA; Zhang W; Lopez-Berestein G; Sood AK
    Nat Commun; 2020 Jun; 11(1):2867. PubMed ID: 32493919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1
    Verma V; Shrimali RK; Ahmad S; Dai W; Wang H; Lu S; Nandre R; Gaur P; Lopez J; Sade-Feldman M; Yizhak K; Bjorgaard SL; Flaherty KT; Wargo JA; Boland GM; Sullivan RJ; Getz G; Hammond SA; Tan M; Qi J; Wong P; Merghoub T; Wolchok J; Hacohen N; Janik JE; Mkrtichyan M; Gupta S; Khleif SN
    Nat Immunol; 2019 Nov; 20(11):1555. PubMed ID: 31551574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Author Correction: L1 drives IFN in senescent cells and promotes age-associated inflammation.
    De Cecco M; Ito T; Petrashen AP; Elias AE; Skvir NJ; Criscione SW; Caligiana A; Brocculi G; Adney EM; Boeke JD; Le O; Beauséjour C; Ambati J; Ambati K; Simon M; Seluanov A; Gorbunova V; Slagboom PE; Helfand SL; Neretti N; Sedivy JM
    Nature; 2019 Aug; 572(7767):E5. PubMed ID: 31296937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Author Correction: Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolism.
    Nishimura K; Murakami T; Sakurai T; Miyoshi M; Kurahashi K; Kishi S; Tamaki M; Tominaga T; Yoshida S; Nagai K; Abe H; Hui SP; Kotani K; Doi T
    Sci Rep; 2019 Dec; 9(1):20270. PubMed ID: 31882578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.
    Färkkilä A; Gulhan DC; Casado J; Jacobson CA; Nguyen H; Kochupurakkal B; Maliga Z; Yapp C; Chen YA; Schapiro D; Zhou Y; Graham JR; Dezube BJ; Munster P; Santagata S; Garcia E; Rodig S; Lako A; Chowdhury D; Shapiro GI; Matulonis UA; Park PJ; Hautaniemi S; Sorger PK; Swisher EM; D'Andrea AD; Konstantinopoulos PA
    Nat Commun; 2020 May; 11(1):2543. PubMed ID: 32424117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author Correction: DRP-1-mediated apoptosis induces muscle degeneration in dystrophin mutants.
    Scholtes C; Bellemin S; Martin E; Carre-Pierrat M; Mollereau B; Gieseler K; Walter L
    Sci Rep; 2020 Jul; 10(1):11665. PubMed ID: 32647220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
    Sci Rep; 2019 Dec; 9(1):18771. PubMed ID: 31801957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author Correction: Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade.
    Li L; Chen K; Wang T; Wu Y; Xing G; Chen M; Hao Z; Zhang C; Zhang J; Ma B; Liu Z; Yuan H; Liu Z; Long Q; Zhou Y; Qi J; Zhao D; Gao M; Pei D; Nie J; Ye D; Pan G; Liu X
    Nat Metab; 2020 Oct; 2(10):1179. PubMed ID: 33033400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.